Sachiko Kawana

891 total citations
17 papers, 590 citations indexed

About

Sachiko Kawana is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Sachiko Kawana has authored 17 papers receiving a total of 590 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 4 papers in Immunology. Recurrent topics in Sachiko Kawana's work include Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Treatments and Mutations (6 papers) and CAR-T cell therapy research (2 papers). Sachiko Kawana is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Treatments and Mutations (6 papers) and CAR-T cell therapy research (2 papers). Sachiko Kawana collaborates with scholars based in Japan. Sachiko Kawana's co-authors include Shunichi Sugawara, Yuichiro Kimura, Kyoji Tsurumi, Atsushi Nakamura, Yosuke Kawashima, Hisashi Shimizu, Ryohei Saito, Tomoiki Aiba, Yutaka Domeki and Jun Sugisaka and has published in prestigious journals such as PLoS ONE, Annals of Oncology and British Journal of Dermatology.

In The Last Decade

Sachiko Kawana

15 papers receiving 585 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sachiko Kawana Japan 7 503 249 115 64 53 17 590
Jun Sugisaka Japan 8 602 1.2× 287 1.2× 109 0.9× 43 0.7× 51 1.0× 20 680
Seonggyu Byeon South Korea 11 283 0.6× 195 0.8× 66 0.6× 128 2.0× 46 0.9× 30 442
Anne-Laure Voisin France 11 739 1.5× 153 0.6× 171 1.5× 68 1.1× 122 2.3× 19 892
Raphael Brandão Moreira United States 11 504 1.0× 369 1.5× 116 1.0× 18 0.3× 52 1.0× 30 719
P. Jacoulet France 13 577 1.1× 481 1.9× 76 0.7× 35 0.5× 103 1.9× 53 823
Robert S. Brody United States 6 269 0.5× 176 0.7× 42 0.4× 100 1.6× 92 1.7× 11 453
Mario R. Velasco United States 13 406 0.8× 162 0.7× 70 0.6× 41 0.6× 48 0.9× 23 646
Audrey Simonaggio France 10 445 0.9× 278 1.1× 82 0.7× 24 0.4× 45 0.8× 23 567
Ewa Chmielowska Poland 12 251 0.5× 132 0.5× 46 0.4× 119 1.9× 24 0.5× 44 468
Florian Huemer Austria 13 323 0.6× 133 0.5× 62 0.5× 79 1.2× 35 0.7× 46 502

Countries citing papers authored by Sachiko Kawana

Since Specialization
Citations

This map shows the geographic impact of Sachiko Kawana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sachiko Kawana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sachiko Kawana more than expected).

Fields of papers citing papers by Sachiko Kawana

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sachiko Kawana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sachiko Kawana. The network helps show where Sachiko Kawana may publish in the future.

Co-authorship network of co-authors of Sachiko Kawana

This figure shows the co-authorship network connecting the top 25 collaborators of Sachiko Kawana. A scholar is included among the top collaborators of Sachiko Kawana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sachiko Kawana. Sachiko Kawana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Sugisaka, Jun, Yukihiro Toi, Yosuke Kawashima, et al.. (2023). Efficacy of paclitaxel‐carboplatin with bevacizumab as a late‐line therapy for patients with advanced nonsquamous non‐small cell lung cancer: A platinum rechallenge. Thoracic Cancer. 14(31). 3140–3146. 1 indexed citations
2.
Aiba, Tomoiki, Jun Sugisaka, Hisashi Shimizu, et al.. (2021). Gene expression signatures as candidate biomarkers of response to PD-1 blockade in non-small cell lung cancers. PLoS ONE. 16(11). e0260500–e0260500. 6 indexed citations
3.
Kawana, Sachiko, Ryoko Saito, Yasuhiro Miki, et al.. (2020). Suppression of tumor immune microenvironment via microRNA‐1 after epidermal growth factor receptor‐tyrosine kinase inhibitor resistance acquirement in lung adenocarcinoma. Cancer Medicine. 10(2). 718–727. 14 indexed citations
4.
Toi, Yukihiro, Yuichiro Kimura, Yutaka Domeki, et al.. (2019). Association of low body surface area with dose reduction and/or discontinuation of nintedanib in patients with idiopathic pulmonary fibrosis: a pilot study.. PubMed Central. 36(1). 74–78. 6 indexed citations
5.
Toi, Yukihiro, Shunichi Sugawara, Mari Aso, et al.. (2019). P1.16-29 Profiling Immune-Related Adverse Events (irAEs) in Patients with Anti-PD-1 for Advanced Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 14(10). S598–S599. 1 indexed citations
6.
7.
Aso, Mari, Yukihiro Toi, Jun Sugisaka, et al.. (2019). Association Between Skin Reaction and Clinical Benefit in Patients Treated with Anti-Programmed Cell Death 1 Monotherapy for Advanced Non-Small Cell Lung Cancer. The Oncologist. 25(3). e536–e544. 46 indexed citations
8.
Nakamura, Atsushi, Tomoiki Aiba, Sachiko Kawana, et al.. (2019). A Case of Pseudoprogression in Lung Adenocarcinoma Treated with Nivolumab. Haigan. 59(1). 60–65.
9.
Sugisaka, Jun, Shunichi Sugawara, Yukihiro Toi, et al.. (2019). Pembrolizumab plus chemotherapy versus pembrolizumab monotherapy for PD-L1-positive advanced non-small cell lung cancer in the real world. Annals of Oncology. 30. ix112–ix113. 2 indexed citations
10.
Toi, Yukihiro, Shunichi Sugawara, Jun Sugisaka, et al.. (2018). Profiling Preexisting Antibodies in Patients Treated With Anti–PD-1 Therapy for Advanced Non–Small Cell Lung Cancer. JAMA Oncology. 5(3). 376–376. 249 indexed citations
11.
Toi, Yukihiro, Shunichi Sugawara, Yosuke Kawashima, et al.. (2018). Association of Immune-Related Adverse Events with Clinical Benefit in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Nivolumab. The Oncologist. 23(11). 1358–1365. 195 indexed citations
12.
Toi, Yukihiro, Shunichi Sugawara, Yosuke Kawashima, et al.. (2017). P2.07-004 Immune-Related Adverse Events (irAEs) of Nivolumab Predicts Clinical Benefit in Advanced Lung Cancer Patients. Journal of Thoracic Oncology. 12(11). S2417–S2417. 1 indexed citations
13.
Nakamura, Atsushi, Sachiko Kawana, Takuya Oikawa, et al.. (2013). Two Cases of Acute Respiratory Distress Syndrome with High Values of <i>Chlamydophila pneumoniae</i>-Specific Antibodies. Internal Medicine. 52(24). 2789–2793. 2 indexed citations
14.
Kosaka, Sachiko, et al.. (2013). Cutaneous vasculitis and glomerulonephritis associated with C4 deficiency. Clinical and Experimental Dermatology. 38(5). 492–495. 2 indexed citations
15.
Aoki, Masahiko, Yoshiki Niimi, Shinichiro Takezaki, et al.. (2001). CD30+ lymphoproliferative disorder: primary cutaneous anaplastic large cell lymphoma followed by lymphomatoid papulosis.. British Journal of Dermatology. 145(1). 123–126. 25 indexed citations
16.
Kawana, Sachiko, et al.. (2000). Diagnosis and comments: Birt-Hogg-Dubé syndrome. European Journal of Dermatology. 10(5). 1 indexed citations
17.
Kawana, Sachiko & S. Nishiyama. (1992). Serum SC5b-9 (Terminal Complement Complex) Level, a Sensitive Indicator of Disease Activity in Patients with Henoch-Schönlein Purpura. Dermatology. 184(3). 171–176. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jun Sugisaka Breakdown of academic impact, for papers by Seonggyu Byeon Breakdown of academic impact, for papers by Anne-Laure Voisin Breakdown of academic impact, for papers by Raphael Brandão Moreira Breakdown of academic impact, for papers by P. Jacoulet Breakdown of academic impact, for papers by Robert S. Brody Breakdown of academic impact, for papers by Mario R. Velasco Breakdown of academic impact, for papers by Audrey Simonaggio Breakdown of academic impact, for papers by Ewa Chmielowska Breakdown of academic impact, for papers by Florian Huemer
Rankless by CCL
2026